药物监管事务与政策 MSc Drug Regulatory Affairs and Policy

Establishment of the Hong Kong Centre for Medical Products Regulation (CMPR) is one of the highlights in the HKSAR Policy Address 2023. The office is set up to study the potential restructuring and strengthening of the current regulatory and approval regimes for medicine, medical devices and medical technology to accelerate the approval of applications and registration of pharmaceutical products for launching to the market.